Absci (ABSI) Short-term Investments (2022 - 2026)
Absci's (ABSI) quarterly Short-term Investments came in at $117.1 million in Q1 2026, up 34.59% year-on-year from $87.0 million in Q1 2025, and down 5.79% quarter-over-quarter from $124.3 million in Q4 2025.
Absci (ABSI) Short-term Investments (2022 - 2026) Analysis & Trends
Absci has disclosed Short-term Investments across 5 years of filings, most recently posting $117.1 million for Q1 2026.
- Short-term Investments for Q1 2026 came in at $117.1 million, up 34.59% year-over-year; the trailing twelve-month figure through Mar 2026 was $117.1 million (up 34.59% YoY), and the FY2025 annual result was $124.3 million, up 74.5% from the prior year.
- Short-term Investments came in at $117.1 million for Q1 2026 at Absci, down from $124.3 million in the prior quarter.
- In the past five years, Short-term Investments ranged from a high of $143.0 million in Q3 2025 to a low of $25.3 million in Q4 2023.
- The 5-year median for Short-term Investments is $88.9 million (2024), against an average of $90.7 million.
- Across the five-year window, Short-term Investments sank 75.79% in 2023 and surged 181.5% in 2024, its largest moves.
- Absci's Short-term Investments stood at $104.5 million in 2022, then tumbled by 75.79% to $25.3 million in 2023, then soared by 181.5% to $71.2 million in 2024, then jumped by 74.5% to $124.3 million in 2025, then dropped by 5.79% to $117.1 million in 2026.
- The last three Short-term Investments figures came in at $117.1 million (Q1 2026), $124.3 million (Q4 2025), and $143.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Absci | 1.13 Bn | 1.01 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 117.08 Mn |
| Dec 31, 2025 | 124.27 Mn |
| Sep 30, 2025 | 143.00 Mn |
| Jun 30, 2025 | 79.43 Mn |
| Mar 31, 2025 | 86.99 Mn |
| Dec 31, 2024 | 71.21 Mn |
| Sep 30, 2024 | 88.87 Mn |
| Jun 30, 2024 | 102.31 Mn |
| Mar 31, 2024 | 102.71 Mn |
| Dec 31, 2023 | 25.30 Mn |
| Sep 30, 2023 | 43.75 Mn |
| Jun 30, 2023 | 63.54 Mn |
| Mar 31, 2023 | 132.85 Mn |
| Dec 31, 2022 | 104.48 Mn |
| Sep 30, 2022 | 73.99 Mn |